Evidence map›Paper›PMID 42321675›Full record

ArticleBMC ophthalmology2026

Unilateral vision loss as the initial symptom of chronic myeloid leukemia with bilateral retinal infiltration: a case report.

Wei Chen, Bo Qin

Abstract readCase Reports
In one paragraph

Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wei ChenDepartment of Ophthalmology, The University of HongKong-Shenzhen Hospital, Shenzhen, Guangdong, 518053, PR China.
Bo QinShenzhen Aier Eye Hospital,Aier Eye Hospital, Jinan University, No.2048, Huaqiang South Road, Futian District, Shenzhen, Guangdong, 518032, PR China. qinbo2024@ext.jnu.edu.cn.

Funding

HKUSZH Rising Star Funding HKUSZH2026B003Shenzhen Science and Technology Innovation Program JCYJ20230807143413027
6 · The paper itself

Abstract

backgroundOphthalmic manifestations as the initial presentation of chronic myeloid leukemia (CML) are rare. CASE PRESENTATION: This case describes a 38-year-old man who presented with unilateral severe vision loss alongside bilateral ocular findings, including intraretinal hemorrhages, vascular tortuosity, cotton wool spots, and optic disc edema. Ophthalmic imaging, particularly optical coherence tomography (OCT), revealed bilateral retinal involvement, which was more severe in the left eye despite worse vision in the right eye. Systemic evaluation revealed critical hyperleukocytosis, splenomegaly, and Philadelphia chromosome positivity, confirming CML. The subsequent MRI during remission showed no abnormality. Treatment with hydroxyurea and nilotinib rapidly normalized white blood cell counts and reached major molecular response (MMR) along with complete visual recovery and normal retina and optic nerve.

conclusionsThis case highlights the importance of recognizing ocular signs as potential indicators of life-threatening systemic diseases such as CML, warranting prompt diagnosis and intervention. Ocular signs not only help to confirm the primary diagnosis, but also may serve as a useful adjunctive marker for monitoring treatment response.

Indexed as

BlindnessLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRetinal DiseasesAdultAntineoplastic AgentsHumansHydroxyureaMaleTomography, Optical CoherenceAntineoplastic AgentsHydroxyureaChronic myeloid leukemiaOphthalmic manifestationsPhiladelphia chromosome

Identifiers

PMID42321675
PMCPMC13528082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.